Home›Companies›Healthcare›Tetrous

Tetrous, Inc.

Bone-fiber implants for surgeons repairing tendons and ligaments.

Updated Nov 10, 2026·Latest SEC filing Apr 22, 2026·Suggest an edit

About Tetrous

Tetrous is a private company based in Sherman Oaks, California. It has reported $2,185,663 raised in two offerings on Form D since December 2023. Its chief executive is Bradley Patt.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 8, 2026Apr 22, 2026$1,741,024of $4.0M target64$27,204EquityRule 506(b)Form D ↗
Dec 12, 2023Dec 21, 2023amended Dec 22, 2023$444,639of $5.0M target2$222KEquity, Securities on exerciseRule 506(c)Form D/A ↗1 earlier filing
Total, two offerings$2,185,663

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Tetrous's Form D filed Apr 22, 2026.

Nikhil Verma
Nikhil Verma
Director
Andy Carter
Andy Carter
Co-founder, Chief Technology Officer, and Director
John Bojanowski
John Bojanowski
Chief Commercial Officer and Director
Simon Berry
Simon Berry
Director
Jan Iwanczyk
Jan Iwanczyk
Director
Bradley Patt
Bradley Patt
Co-founder, CEO, and Chairman of the Board

Earlier filings also listed Frank Phillips (director, last listed Dec 2023).

Sources

  1. SECTetrous, Inc. Form D, filed Dec 21, 2023
  2. SECTetrous, Inc. filing history
  3. CompanyAbout Tetrous
  4. CompanyExpanded clinical applications of EnFix